Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mitral valve prolapse and pregnancy].

G Plotti, G Tropeano, P Colucci

    Minerva Medica
    |November 3, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Incidence and predictive factors for complications after uterine leiomyoma embolization.

    Human reproduction (Oxford, England)·2014
    Same author

    The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study.

    Human reproduction (Oxford, England)·2012
    Same author

    [Testing a nutritional and taste education intervention approach to increase vegetables and fruit consumption among children].

    Annali di igiene : medicina preventiva e di comunita·2008
    Same author

    [Vulvovaginal candidiasis: a therapeutic approach].

    Minerva ginecologica·2005
    Same author

    In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates.

    The Journal of antimicrobial chemotherapy·2004
    Same author

    Effect of incremental doses of folate on homocysteine and metabolically related vitamin concentrations in nondiabetic patients on peritoneal dialysis.

    ASAIO journal (American Society for Artificial Internal Organs : 1992)·2003
    Same journal

    Tumor-induced osteomalacia: a 2026 update.

    Minerva medica·2026
    Same journal

    Smoking, healthy lifestyle and adolescence.

    Minerva medica·2026
    Same journal

    How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

    Minerva medica·2026
    Same journal

    Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

    Minerva medica·2026
    Same journal

    Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

    Minerva medica·2026
    Same journal

    Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

    Minerva medica·2026
    See all related articles

    This study found no significant differences in outcomes for pregnant individuals with mitral valve prolapse (MVP) compared to a control group. Pregnancy with MVP does not appear to increase obstetric or neonatal risks.

    Area of Science:

    • Cardiology
    • Obstetrics
    • Perinatology

    Context:

    • Mitral valve prolapse (MVP) is a common cardiac condition.
    • Pregnancy presents unique physiological challenges for individuals with cardiac conditions.
    • Understanding the impact of MVP on pregnancy outcomes is crucial for clinical management.

    Purpose:

    • To assess the clinical parameters and obstetric/neonatal outcomes in pregnant patients with mitral valve prolapse (MVP).
    • To compare these outcomes with a matched control group without MVP.

    Summary:

    • A retrospective analysis of 13 pregnant cases with MVP was conducted.
    • Key clinical parameters, obstetric complications, and neonatal outcomes were evaluated.
    • No statistically significant differences were observed between the MVP group and the control group.

    Related Experiment Videos

    Impact:

    • The findings suggest that mitral valve prolapse (MVP) may not significantly increase obstetric or neonatal risks during pregnancy.
    • This information can aid in counseling and managing pregnant patients with MVP.
    • Further research with larger cohorts may be warranted to confirm these findings.